Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
SAI Life Sciences Ltd. ( (IN:SAILIFE) ) has issued an update.
Sai Life Sciences has allotted 397,911 fully paid-up equity shares of Re 1 each following the exercise of employee stock options under its Employees Stock Option Plan 2008 and Management ESOP Plan 2018, as approved by the board on 5 February 2025. The new allotment, listed on BSE and NSE, modestly expands the company’s equity base and reflects the ongoing use of share-based compensation to align management and employees with shareholder interests, potentially diluting existing holdings slightly while reinforcing long-term incentive structures within the organisation.
More about SAI Life Sciences Ltd.
Sai Life Sciences Limited is an India-based life sciences company whose equity shares are listed on BSE and the National Stock Exchange of India. The company operates from corporate and registered offices in Hyderabad, Telangana, and is engaged in the broader chemicals and life sciences sector, with its shares carrying a face value of Re 1 each under the ISIN INE570L01029.
Average Trading Volume: 15,972
Technical Sentiment Signal: Buy
Current Market Cap: 170.9B INR
See more insights into SAILIFE stock on TipRanks’ Stock Analysis page.